Trial intelligence / Profile preview

Real-world phase 4 study of surufatinib in neuroendocrine tumors

ChiCTR2100049999Phase 4Recruiting

Sponsor

Shanghai General Hospital

Start

Jun 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1